Ophthalmology Times spoke with Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis about how her ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

PYC Therapeutics (ASX:PYC) has jumped on Friday as it moves on the the next stage of its escalating single-dose study using its drug PYC-001 to treat a genetic children’s disease causing blindness.

PYC is looking at therapies across retinitis pigmentosa, polycystic kidney disease, genetic condition Phelan McDermid syndrome, and autosomal dominant optic atrophy, with other undisclosed ...

Jan. 30, 2025 — Researchers developed a new optical system that uses holograms to encode information, creating a level of encryption that traditional methods cannot ... Optical Fiber Sensor ...